Shyamkamal Inv (505515)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Low P/E of 9.75 and PEG of 0.04 make the stock look statistically inexpensive on reported earnings.
• Piotroski F-Score of 7/9 indicates a reasonably healthy financial profile based on available figures.
• Latest quarter is profitable with ₹1 Cr net profit despite zero disclosed sales.
• Modest dividend yield of 1.56% provides some shareholder return, though small.

Concerns

• Zero sales growth and zero profit growth; latest quarter shows ₹0 Cr revenue, so earnings quality is unclear.
• P/B of 7.29 against book value of ₹1.68 leaves very little margin of safety.
• ROCE of 6.88% is low and ROE of 10.61% is mediocre; no evidence of a durable moat.
• Market cap of ₹17 Cr, N/A promoter holding and insufficient data make governance and liquidity difficult to assess.

AI Analysis

Let me start with what I know: Shyamkamal Inv is a ₹17 Cr financial-services microcap, trading at ₹12.25. At 9.75 times earnings and a PEG of 0.04, the headline looks like a bargain. But Graham taught me not to trust a single earnings number. The latest quarter shows ₹1 Cr net profit but zero sales. In financial services, revenue may not be called sales, but an absence of any disclosed top line and 0.00% profit growth makes me wonder if this profit is sustainable or just investment income. The book value is only ₹1.68; at ₹12.25 I am paying 7.29 times the stated net worth. That leaves no margin of safety against asset shrinkage. ROE of 10.61% is modest, and ROCE of 6.88% is worse. A company earning 10.61% on equity with zero growth is not a compounding machine. The dividend yield of 1.56% offers little compensation. Piotroski F-Score of 7/9 is a plus, but with promoter holding unavailable and a FairStock Score of 'insufficient data', I cannot verify governance or insider alignment. In a tiny ₹17 Cr financial shell, that missing information is critical. Would I buy this? Not at 7.3 times book and no growth. If the earnings are backed by cash, the valuation might be justified, but I don't have enough facts. This looks like a slow grower at best, and an asset trap at worst. I would rather wait until either book value grows into this price, or the business proves its profitability over several quarters. Price is what you pay; value is what you get. Here, I cannot see the value.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer